Population-based study of lung function and incidence of heart failure hospitalisations

Thorax

Volumn 65, Issue 7, 2010, Pages 633-638

  Engström, Gunnar ^a   Melander, Olle ^a   Hedblad, Bo ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HAZARD RATIO; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPERTENSION; INCIDENCE; LIPID BLOOD LEVEL; LUNG FUNCTION; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; SPIROMETRY; STROKE; LEUKOCYTE COUNT; LUNG DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICS; SWEDEN; VITAL CAPACITY;

ADULT; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HEART FAILURE; HOSPITALIZATION; HUMANS; HYPERTENSION; INCIDENCE; LEUKOCYTE COUNT; LUNG DISEASES; MALE; MIDDLE AGED; SMOKING; SWEDEN; VITAL CAPACITY;

EID: 77955297771     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.135392     Document Type: Article

References (35)

1. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005;127:1952-9.
2. Johnston AK, Mannino DM, Hagan GW, et al. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax 2008;63:599-605.
3. Hole DJ, Watt GCM, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996;313:711-15.
4. Engström G, Hedblad B, Valind S, et al. Asymptomatic leg and carotid atherosclerosis in smokers is related to degree of ventilatory capacity: longitudinal and cross-sectional results from 'Men born in 1914', Sweden. Atherosclerosis 2001;155:237-43.
5. Zureik M, Kauffmann F, Touboul PJ, et al. Association between peak expiratory flow and the development of carotid atherosclerotic plaques. Arch Intern Med 2001;161:1669-76.
6. Lange P, Nyboe J, Appleyard M, et al. Spirometric findings and mortality in never-smokers. J Clin Epidemiol 1990;43:867-73.
7. Cowie MR, Wood DA, Coats AJ, et al. Incidence and aetiology of heart failure: a population-based study. Eur Heart J 1999;20:421-8.
8. Butler J, Kalogeropoulos A, Georgiopoulou V; for the Health ABC Study. Incident heart failure prediction in the elderly: the Health ABC heart failure score. Circ Heart Fail 2008;1:125-33.
9. Wilhelmsen L, Rosengren A, Eriksson H, et al. Heart failure in the general population of menemorbidity, risk factors and prognosis. J Intern Med 2001;249:253-61.
10. Kannel WB, Seidman JM, Fercho W, et al. Vital capacity and congestive heart failure. The Framingham Study. Circulation 1974;49:1160-6.
11. Calhoun JA, Cullen GE, Harrison TR, et al. Studies in congestive heart failure: XIV. Orthopnea: its relation to ventilation, vital capacity, oxygen saturation and acid-base condition of arterial and jugular blood. J Clin Invest 1931;10:833-55.
12. Enright PL, Kronmal RA, Smith VE, et al. Reduced vital capacity in elderly persons with hypertension, coronary heart disease, or left ventricular hypertrophy. The Cardiovascular Health Study. Chest 1995;107:28-35.
13. Gottdiener JS, Arnold AM, Aurigemma GP, et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000;35:1628-37.
14. Eriksson H, Svärdsudd K, Larsson B, et al. Risk factors for heart failure in the general population: the study of men born in 1913. Eur Heart J 1989;10:647-56.
15. Berglund G, Nilsson P, Eriksson KF, et al. Long-term outcome of the Malmö preventive project: mortality and cardiovascular morbidity. J Intern Med 2000;247:19-29.
16. Engström G, Melander O, Hedblad B. Leukocyte count and incidence of hospitalizations due to heart failure. A population-based cohort study. Circ Heart Fail 2009;2:217-22.
17. Kristenson H, Trell E. Indicators of alcohol consumption: comparisons between a questionnaire (Mm-MAST), interviews and serum gamma-glutamyl transferase (GGT) in a health survey of middle-aged males. Br J Addict 1982;7:297-304.
18. Engström G, Segelstorm N, Ekberg-Aronsson M, et al. Plasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort study. Thorax 2009;64:211-15.
19. Ekberg-Aronsson M, Pehrsson K, Nilsson JA, et al. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 2005;6:98.
20. Hedblad B, Jonsson S, Nilsson P, et al. Obesity and myocardial infarction: vulnerability related to occupational level and marital status. A 23-year follow-up of an urban male Swedish population. J Intern Med 2002;252:542-50.
21. Ingelsson E, Arnlöv J, Sundström J, et al. The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail 2005;7:787-91.
22. Barr RG, Bluemke DA, Ahmed FS, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010;362:217-27.
23. Lange P, Mogelvang R, Marott JL, et al. Cardiovascular morbidity in COPD: a study of the general population. COPD 2010;7:5-10.
24. Hawkins NM, Petrie MC, Jhund PS, et al. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail 2009;11:130-9.
25. Rutten FH, Cramer MJ, Lammers JW, et al. Heart failure and chronic obstructive pulmonary disease: an ignored combination? Eur J Heart Fail. 2006;8:706-11.
26. Barker DJ, Godfrey KM, Fall C, et al. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ 1991;303:671-5.
27. Barker DJ, Osmond C, Forsén TJ, et al. Trajectories of growth among children who have coronary events as adults. N Engl J Med 2005;353:1802-9.
28. Sparrow D, Weiss ST, Vokonas PS, et al. Forced vital capacity and the risk of hypertension. The Normative Aging Study. Am J Epidemiol 1988;127:734-41.
29. Engström G, Wollmer P, Valind S, et al. Blood pressure increase between 55 and 68 years of age is inversely related to lung function: longitudinal results from the cohort study 'Men born in 1914'. J Hypertens 2001;19:1203-8.
30. Engström G, Hedblad B, Nilsson P, et al. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med 2003;253:574-81.
31. Engström G, Gerhardsson de Verdier M, Dahlbäck M, et al. BP variability and cardiovascular autonomic function in relation to forced expiratory volume: a population-based study. Chest 2009;136:177-83.
32. Brychta RJ, Shiavi R, Robertson D, et al. A simplified two-component model of blood pressure fluctuation. Am J Physiol Heart Circ Physiol 2007;292:H1193-203.
33. Mancia G, Bombelli M, Facchetti R, et al. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension 2007;49:1265-70.
34. Suzuki T, Katz R, Jenny NS, et al. Metabolic syndrome, inflammation, and the incident heart failure in the elderly: the cardiovascular health study. Circ Heart Fail 2008;1:242-8.
35. Vasan RS, Sullivan LM, Roubenoff R, et al. Framingham Heart Study. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the framingham heart study. Circulation 2003;107:1486-91.